Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.30 |
| ▸ | CDK4 | P11802 | 1/20 | 0.30 |
| ▸ | CCND1 | P24385 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24949080 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24949616 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL17742514 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24949618 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24948700 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24949082 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24948689 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24949036 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL20812915 | 0.99 | KDM4E (0.35) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24948218 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1TSPOHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10464895-B2 | Compound, material for organic electroluminescence elements, organic electroluminescence element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-11-05 | — | — | US | disclosed |
| US-20190077754-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10464895-B2 | Compound, material for organic electroluminescence elements, organic electroluminescence element, and electronic device | PIEZO1, RER1, L1CAM | KDM4E 2962/4885ATM 2301/4885L3MBTL1 266/4885 |
| US-20190077754-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, RER1, L1CAM | KDM4E 2962/4885ATM 2301/4885L3MBTL1 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.